Erleada
(er-LEE-duh)
A drug used to
treat prostate cancer that has spread to other parts of the
body and is castration sensitive (has responded to
treatments that lower testosterone levels) and prostate
cancer that has not spread to other parts of the body and
is castration resistant (has not responded to treatments
that lower testosterone levels).
Erleada binds to proteins
called androgen receptors, which are found in some prostate
cancer cells. These proteins bind to androgens (male
hormones) and may cause cancer cells to grow.
Erleada blocks these proteins
and may keep cancer cells from growing. It is a type of
antiandrogen. Also called apalutamide.